A prospective evaluation of rectal bleeding after dose-escalated three-dimensional conformal radiation therapy using an intrarectal balloon for prostate gland localization and immobilization

Urology

Volumn 67, Issue 4, 2006, Pages 780-784

  D'Amico, Anthony V ^a   Manola, Judith ^a   McMahon, Elizabeth ^a   Loffredo, Marian ^a   Lopes, Lynn ^a   Ching, Jane ^a   Albert, Michele ^a   Hurwitz, Mark ^a   Suh, Wonsuk Warren ^a   Vivenzio, Todd A ^a   Beard, Clair ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; HORMONE; HYDROCORTISONE; PROSTATE SPECIFIC ANTIGEN; WARFARIN;

ANTICOAGULANT THERAPY; ARGON PLASMA COAGULATION; ARTICLE; BALLOON; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CLINICAL EXAMINATION; CLINICAL TRIAL; COHORT ANALYSIS; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG MEGADOSE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; IMMOBILIZATION; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE ADENOCARCINOMA; PROSTATE BIOPSY; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RECTUM HEMORRHAGE; SCORING SYSTEM; THREE DIMENSIONAL IMAGING; TREATMENT OUTCOME; TREATMENT PLANNING; TUMOR BIOPSY; UROGENITAL TRACT RADIOGRAPHY;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; GASTROINTESTINAL HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; RADIOTHERAPY, INTENSITY-MODULATED; RECTAL DISEASES; RECTUM;

EID: 33646001415     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2005.10.008     Document Type: Article

References (19)

1. Pollack A., Zagars G.K., Starkschall G., et al. Prostate cancer radiation dose response. results of the M. D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys 53 (2002) 1097-1105
2. Zietman A.L., DeSilvio M., Slater J.D., et al. A randomized trial comparing conventional dose (70.2GyE) and high-dose (79.2GyE) conformal radiation in early stage adenocarcinoma of the prostate. results of an interim analysis of PROG 95-09. (abstract). Int J Radiat Oncol Biol Phys 60 (2004) S131-S132
3. Aubry J., Beaulieu L., Girouard L., et al. Measurements of intrafraction motion and interfraction rotation of prostate by three-dimensional analysis of daily portal imaging with radio-opaque markers. Int J Radiat Oncol Biol Phys 60 (2004) 30-39
4. Ghilezan M.J., Jaffray D.A., Siewerdsen J.H., et al. Prostate gland motion assessed wih cine-magnetic resonance imaging (CINE-MRI). Int J Radiat Oncol Biol Phys 62 (2005) 406-417
5. McNeal J.E., Redwine E.A., Freiha F.S., et al. Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread. Am J Surg Pathol 12 (1988) 897-906
6. Storey M.R., Pollack A., Zagars G., et al. Complications from radiotherapy dose escalation in prostate cancer. preliminary results of a randomized trial. Int J Radiat Oncol Biol Phys 48 (2000) 635-642
7. D'Amico A.V., Manola J., Loffredo M., et al. A practical method to achieve prostate gland immobilization and target verification for daily treatment. Int J Radiat Oncol Biol Phys 51 (2001) 1431-1436
8. McGary J.E., The B.S., Butler E.B., et al. Prostate immobilization using a rectal balloon. J Appl Clin Med Phys 3 (2001) 6-11
9. Zoe R., Beard C., Chen M., et al. Acute gastrointestinal, genitourinary, and dermatological toxicity during dose-escalated 3D-conformal radiation therapy (3CDRT) using an intra-rectal balloon for prostate gland localization and immobilization. Int J Radiat Oncol Biol Phys 62 (2005) 392-396
10. De Crevoisier R., Tucker S.L., Dong L., et al. Increased risk of biochemical and local failure in patients with distended rectum on the planning CT for prostate cancer radiotherapy. Int J Radiat Oncol Biol Phys 62 (2005) 965-973
11. Sanghani M.V., Ching J., Schultz D., et al. Impact of rectal dose from the use of a prostate immobilization and rectal localization device for patients receiving dose escalated 3D conformal radiation therapy. Urol Oncol 22 (2004) 165-168
12. Kaplan E.L., and Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 3 (1958) 457-500
13. Zelefsky M.J., Fuks Z., Hunt M., et al. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. J Urol 166 (2001) 876-881
14. Michalski J.M., Winter K., Purdy J.A., et al. Toxicity after three-dimensional radiotherapy for prostate cancer with RTOG 9406 dose level V. Int J Radiat Oncol Biol Phys 62 (2005) 706-713
15. Zelefsky M.J., Fuks Z., Hunt M., et al. High-dose intensity modulated radiation therapy for prostate cancer. early toxicity and biochemical outcome in 772 patients. Int J Radiat Oncol Biol Phys 53 (2002) 1111-1116
16. Langen K.M., Pouliot J., Anezinos C., et al. Evaluation of ultrasound-based prostate localization for image-guided radiotherapy. Int J Radiat Oncol Biol Phys 57 (2003) 635-644
17. Shipley W.U. The advantage of an x-ray visible marker of the prostatic apex. Int J Radiat Oncol Biol Phys 27 (1993) 985
18. Roach III M., DeSilvio M., Lawton C., et al. Phase III trial comparing whole-pelvic versus prostate-only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression. Radiation Therapy Oncology Group 9413. J Clin Oncol 21 (2003) 1904-1911
19. Teh B.S., Mai W.Y., Uhl B.M., et al. Intensity-modulated radiation therapy (IMRT) for prostate cancer with the use of a rectal balloon for prostate immobilization. Acute toxicity and dose-volume analysis. Int J Radiat Oncol Biol Phys 49 (2001) 705-712